This approach mimics the combination of pharmacotherapy (DBH inhibitor) with psychotherapy (context exposition in a safe environment) for the treatment of PTSD, which may contribute to resilience and coping with the trauma. The gene discussed is DBH; the disease is post-traumatic stress disorder.